Jennifer Lynn Taylor

Title: Innovations by Jennifer Lynn Taylor

Introduction

Jennifer Lynn Taylor is an accomplished inventor based in McDonald, PA (US). She has made significant contributions to the field of immunology and cancer treatment through her innovative research and patents. With a total of 2 patents, her work focuses on developing immunogenic peptides that can elicit immune responses and treat cancer.

Latest Patents

Jennifer's latest patents include groundbreaking work on immunogenic tumor-associated stromal cell antigen peptides and methods of their use. These patents disclose immunogenic peptides derived from tumor-associated stromal cell antigens, including various combinations of such peptides. In some instances, these peptides are designed to elicit an immune response, while in others, they are aimed at treating cancer. Additionally, her patents describe methods for decreasing the vascularization of tumors using a Protein Delta Homolog 1 (DLK1) protein or a nucleic acid encoding the protein.

Career Highlights

Jennifer Lynn Taylor is affiliated with the University of Pittsburgh, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies and immunological advancements.

Collaborations

Some of her notable coworkers include Devin B Lowe and Xi Zhao, who contribute to her research initiatives and collaborative projects.

Conclusion

Jennifer Lynn Taylor's innovative work in immunology and cancer treatment exemplifies the importance of research in developing new therapeutic methods. Her contributions through her patents are paving the way for advancements in medical science.